image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Trainline

November 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRN
  • Price:
  • 338p
The shares rallied from a low of 255p after online train ticketing market-place, Trainline, said trading was ahead of expectations at every level in H1 2022. Net ticket sales were £1bn (Numis forecast: £819m) with Q2 ‘22 recovering to 71% of Q2 ’20, the highest since the crisis started. Within its markets, the UK was the strongest with ticket sales in Q2 back to 95% of pre-Covid levels.Net debt reduced from £241m in February to £169m in August.Trainline has also upgraded its guidance for FY’22 to EBITDA between £35m-£40m, against current consensus of £22m EBITDA.In response, Numis forecasts £35m EBITDA and eps of 0.4p for the year ended Feb ’22, ris ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X